Marta
Rodríguez González
Profesora Asociada CC. Salud
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (3)
2021
-
Peripheral T-cell lymphoma: molecular profiling recognizes subclasses and identifies prognostic markers
Blood Advances, Vol. 5, Núm. 24, pp. 5588-5598
2019
-
Selective BTK inhibition improves bendamustine therapy response and normalizes immune effector functions in chronic lymphocytic leukemia
International Journal of Cancer, Vol. 144, Núm. 11, pp. 2762-2773
2017
-
SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphoma
Blood, Vol. 130, Núm. 4, pp. 501-513